Abstract
EMERGE Study: An Open-label Evaluation of the Efficacy and Safety of AXS-07 (MoSEIC™ meloxicam-rizatriptan) for Migraine in Adults with Prior Inadequate Response to an Oral CGRP Inhibitor (P6-12.006)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have